AT275736B - Verfahren zur Herstellung von Lösungen basisch reagierender Arzneistoffe - Google Patents

Verfahren zur Herstellung von Lösungen basisch reagierender Arzneistoffe

Info

Publication number
AT275736B
AT275736B AT508167A AT508167A AT275736B AT 275736 B AT275736 B AT 275736B AT 508167 A AT508167 A AT 508167A AT 508167 A AT508167 A AT 508167A AT 275736 B AT275736 B AT 275736B
Authority
AT
Austria
Prior art keywords
solutions
preparation
basic reacting
drugs
reacting drugs
Prior art date
Application number
AT508167A
Other languages
English (en)
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Application granted granted Critical
Publication of AT275736B publication Critical patent/AT275736B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT508167A 1966-06-01 1967-05-31 Verfahren zur Herstellung von Lösungen basisch reagierender Arzneistoffe AT275736B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DED0050229 1966-06-01
DE1967D0052519 DE1617438C3 (de) 1966-06-01 1967-03-15 Verfahren zur Herstellung von Lösungen basisch-reagierender Arzneistoffe
DED0052520 1967-03-15

Publications (1)

Publication Number Publication Date
AT275736B true AT275736B (de) 1969-11-10

Family

ID=27209863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT508167A AT275736B (de) 1966-06-01 1967-05-31 Verfahren zur Herstellung von Lösungen basisch reagierender Arzneistoffe

Country Status (7)

Country Link
AT (1) AT275736B (de)
BE (1) BE699315A (de)
CH (2) CH567419A5 (de)
DE (3) DE1617427C3 (de)
GB (1) GB1132933A (de)
NL (1) NL6707558A (de)
SE (1) SE365943B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326089A1 (de) * 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten

Also Published As

Publication number Publication date
DE1617438C3 (de) 1980-07-31
BE699315A (de) 1967-11-03
GB1132933A (en) 1968-11-06
NL6707558A (de) 1967-12-04
DE1617439A1 (de) 1971-03-25
CH567419A5 (de) 1975-10-15
DE1617427C3 (de) 1975-04-24
DE1617438B2 (de) 1979-11-22
CH539436A (de) 1973-09-14
SE365943B (de) 1974-04-08
DE1617438A1 (de) 1971-03-25
DE1617427B2 (de) 1974-08-29
DE1617427A1 (de) 1971-04-01

Similar Documents

Publication Publication Date Title
CH487916A (de) Verfahren zur Herstellung von 2-Cycloalkylamino-oxazolinen
CH484108A (de) Verfahren zur Herstellung von Pyrrylaminoäthanolen
CH490294A (de) Verfahren zur Herstellung von 3-Methylpentenen
CH485731A (de) Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol
CH484016A (de) Verfahren zur Herstellung von Hydrindacenen
CH479626A (de) Verfahren zur Herstellung von Organooxysilanen
CH491064A (de) Verfahren zur Herstellung von Diaceton-L-sorbose
CH487177A (de) Verfahren zur Herstellung von Thiaimidazolidinen
CH491857A (de) Verfahren zur Herstellung von Phenoxyaminoalkanolen
CH484155A (de) Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH490358A (de) Verfahren zur Herstellung von 17a-Äthinyl-17B-hydroxysteroiden
CH472381A (de) Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden
AT275736B (de) Verfahren zur Herstellung von Lösungen basisch reagierender Arzneistoffe
AT277957B (de) Verfahren zur Herstellung von Alkenonen
CH506556A (de) Verfahren zur Herstellung von Chinolylmethylpenicillinen
CH495333A (de) Verfahren zur Herstellung von Trihalogenäthylglycinaten
CH477470A (de) Verfahren zur Herstellung von Ribofuranosiden
CH509249A (de) Verfahren zur Herstellung von 3-Aminoalkyl-3-arylindanolen-1
CH490377A (de) Verfahren zur Herstellung von Aminohydrinen
CH487860A (de) Verfahren zur Herstellung von Arylsulfonylsemicarbaziden
CH480435A (de) Verfahren zur Herstellung von N-Demethyl-N-äthyllincomycin C
AT274780B (de) Verfahren zur Herstellung von 1-Acylaminoadamantanen
AT269873B (de) Verfahren zur Herstellung von 2-Nitroimidazolen
AT273165B (de) Verfahren zur Herstellung von Diphenylsilandiolen
AT276763B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen